drugset / Trial / NCT05484505

Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan

NCT05484505

RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized, controlled, two-armed, single-blinded, superiority trial with 1:1 allocation ratio Nicotine Replacement Therapy(NRT)

Timeline

Start
2023-07-01
Primary completion
2024-12-31
Completion
2024-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Nicotine Unknown 7 mg
Background Nicotine Unknown 14 mg
Background Nicotine Unknown 21 mg
Background Nicotine Unknown 2 mg
Background Nicotine Unknown 4 mg

Indications

No indication recorded.